Viral Missiles: Research Advances in Achieving Efficient Targeted Delivery of Cancer Therapeutics Using Viral Vectors
DOI:
https://doi.org/10.61173/581acg31Keywords:
Virus vector, Targeted drug delivery, Cancer treatment, Gene therapy, Precision medicineAbstract
Cancer has become one of the main diseases threatening human health. Although traditional methods such as surgery, radiotherapy and chemotherapy have improved the prognosis of patients to some extent, there are still various problems, such as strong side effects, high recurrence rate and insufficient targeting. With the development of the concepts of precision medicine and targeted therapy, viral vectors have become an important tool to construct new targeted drug delivery systems, because they have the ability of cell infection and gene transfer.This study conducted a systematic review of relevant literature, the application strategy and research progress of virus vector in achieving efficient targeted drug delivery in tumors are comprehensively expounded, and its advantages and mechanisms in drug loading, gene regulation and immune activation are emphatically introduced. The results show that after structural modification, promoter improvement and receptor-mediated recognition, viral vectors can significantly improve drug delivery efficiency and targeting characteristics, and achieve this goal on the basis of ensuring safety.This conclusion provides important theoretical basis and technical direction for precision treatment of tumors. During this period, it also faces the problem of controlling immune response and improving drug delivery efficiency in solid tumors, so it is necessary to explore more engineering improvement methods and transformation ways.
References
[1] Zhang Tingran, Tian Hong, Yao Wenbing. Advances in the Application of Viral Vectors in Cancer Vaccines. Pharmaceutical Biotechnology, 2024, 31(06): 705-710.
[2] Zhong Chunlian, Fang Changjian, Zhou Guiyu, et al. Research on Nanographene Oxide as a Clinical Drug Carrier in Tumour Therapy. Bulletin of Chinese Pharmacology, 2024, 40(08): 1413-1418.
[3] Seclì L, Avalle L, Brignone C, et al. Personalized Cancer Vaccines Go Viral: Viral Vectors in Cancer Immunotherapy. International Journal of Molecular Sciences, 2023, 24(23): 16591.
[4] Liu Yongfei. Application of carrier-free nanomedicines in combined chemo-gene therapy for tumours. Fuzhou University, 2022.
[5] Raguz J, Pinto C, Pölzlbauer T, et al. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. J Immunother Cancer, 2024, 12(4).
[6] Makafui D D, Sandoval E V T, Emmanuel F, et al. Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. Drug Deliv Transl Res, 2023, 13(11): 2719-2738.
[7] D. I. O., A. V. V., S. D. Z., et al. Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment. Viruses, 2023, 15(1): 182.
[8] Ester G, Sarah R. DC-targeting lentivectors for cancer immunotherapy. Immunotherapy Advances, 2023, 3(1): ltad023.
[9] Shrey K, Tanmay K, Suyash D, et al. Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer. BioTech, 2022, 11(1): 6.
[10] Shuang F, Xiaodong X, Yu M, et al. RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy. J Drug Target, 2019, 27(1): 1-11.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
